TP53 and colorectal carcinoma: This data was then used to investigate the mutational status of the major signaling pathways altered in CRC (i.e., those centered on P53, Wnt, TGF-Beta, and VEGF), by comparing the frequencies with which the genes involved in these pathways were mutated (Figure 3).